Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| CNAT (Conatus Pharmaceuticals Inc) | NA | -33.42% | -52.45% | -35.98% | NA | NA | NA | … | … |
Data as of 05/26/2020, Common starting date is 07/25/2013
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| CNAT (Conatus Pharmaceuticals Inc) | 07/25/2013 | 05/26/2020 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -17.01 | -33.42 | -52.45 | -35.98 | NA | NA | NA | … | … | 39.00 | -76.88 | -62.55 | -12.33 | 82.99 | -58.86 | 8.53 | -32.11 |
| Sharpe Ratio | NA | -0.37 | -0.56 | -0.49 | NA | NA | NA | … | … | 1.06 | -0.57 | -0.68 | -0.49 | 0.39 | -0.88 | -0.10 | -1.37 |
| Standard Deviation(%) | NA | 153.64 | 132.29 | 120.76 | NA | NA | NA | … | … | 109.11 | 175.64 | 123.41 | 65.02 | 123.07 | 88.34 | 104.68 | 58.78 |
| Draw Down(%) | NA | 74.87 | 96.66 | 97.15 | NA | NA | NA | … | … | 49.20 | 91.06 | 84.40 | 55.30 | 55.88 | 75.63 | 62.67 | 43.18 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 05/26/2020, Common starting date is 07/25/2013
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CNAT (Conatus Pharmaceuticals Inc) |
-65.06%
Apr 2017 – Apr 2020 |
-50.90%
Jun 2014 – Jun 2019 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CNAT (Conatus Pharmaceuticals Inc) |
12.60%
Aug 2015 – Aug 2018 |
-6.83%
Nov 2013 – Nov 2018 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart
